Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biomea Fusion, Inc. - BMEA


NEW YORK, June 24, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biomea Fusion, Inc. ("Biomea" or the "Company") (NASDAQ: BMEA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether Biomea and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action] 

On June 6, 2024, Biomea issued a press release "announc[ing] that the Company has received notice from the U.S. Food and Drug Administration (FDA) that a full clinical hold has been placed on Biomea's ongoing Phase I/II clinical trials of the Company's investigational covalent menin inhibitor BMF-219 in type 2 and type 1 diabetes (COVALENT-111 and COVALENT-112), respectively." The press release stated that "[t]he FDA cited deficiencies based on the level of possible drug-induced hepatotoxicity observed in the completed Dose Escalation Phase of COVALENT-111." 

On this news, Biomea's stock price fell $7.13 per share, or 63.27%, to close at $4.14 per share on June 7, 2024.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP


These press releases may also interest you

at 05:01
Ochama, JD.com's innovative omni-channel retailer, recently announced the launch of "ochama 1h delivery," underscoring the company's dedication to providing swift and reliable shopping experiences that meet the evolving needs of its customers. This...

at 05:00
International Petroleum Corporation (IPC or the Corporation) is pleased to announce that IPC repurchased a total of 276,418 IPC common shares (ISIN: CA46016U1084) during the period of July 8 to 12, 2024 under IPC's normal course issuer bid / share...

at 04:54
Kojamo lowers its outlook for 2024 for total revenue and for Funds From Operations (FFO). New outlook for 2024 Kojamo estimates that in 2024, the Group's total revenue will increase by 2-4 per cent year-on-year. In addition, Kojamo estimates that...

at 04:10
Minimum Deposit Casinos (MDC), a premier online resource for casino enthusiasts, is delighted to announce the successful completion of its comprehensive website redesign. Initiated in May, this ambitious project has seen the migration of all pages...

at 04:00
Wirex, the leading Web3 money app, and Visa, a world leader in digital payments, are thrilled to announce a partnership to further the use of digital currencies in the UK and the European Economic Area (EEA). This collaboration will explore new...

at 03:28
A news report from chinadaily.com.cn: China's policymakers are gathering in Beijing on Monday for an epoch-making meeting to advance the nation's reform and opening-up, amid high expectations that key steps will be introduced to further energize the...



News published on and distributed by: